keyboard_arrow_up

Crohns Disease (CD) Market - Global Industry Analysis 2015 Size and Forecast 2019

CD is an ongoing condition that causes inflammation of the digestive tract or the GI tract. CD may also be named as ileitis, granulomatous enteritis or colitis, regional enteritis, or terminal ileitis. The exact etiology of CD is unknown. Usually, CD affects the small intestine and the beginning of the large intestine. However, the disease can disturb any part of the GI tract, from the mouth to the anus. CD can occur at any age; however, it is usually first diagnosed in people in their teens and twenties.

Global CD market to grow at a CAGR of 2.84 percent over the period 2014-2019.
 
Covered in this Report
 
This report covers the present scenario and the growth prospects of the Global CD market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of CD. The Global CD market can be divided into five segments: 5-ASA, Antibiotics, Biologicals, Corticosteroids, and Immunomodulators.
 
 
Global CD Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global CD market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
 
Key Regions
 
Americas
APAC
EMEA
 
Key Vendors
 
AbbVie
Astra Zeneca
Biogen Idec
Johnson & Johnson
Takeda Pharmaceutical
UCB
 
Other Prominent Vendors
 
Amgen
Boehringer Ingelheim
Celltrion
ChemoCentryx
Ferring Pharmaceuticals
Merck
Mitsubishi Tanabe
Novartis
Novo Nordisk
Pfizer
 
 
Market Driver
 
Increase in CD Prevalence
For a full, detailed list, view our report
 
Market Challenge
 
Multiple Patent Expiry
For a full, detailed list, view our report
 
Market Trend
 
Increase in Strategic Collaborations
For a full, detailed list, view our report